The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]-Reference-Cited by-同舟云学术

The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]

Published:2020-03-06 Issue:3 Volume:15 Page:e0229900
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Clarke Stephen John^ORCID,Burge Matthew,Feeney Kynan,Gibbs Peter,Jones Kristian,Marx Gavin,Molloy Mark P.,Price Timothy,Reece William H. H.,Segelov Eva,Tebbutt Niall C.

Funder

Roche Products, Pty. Limited

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference22 articles.

1. Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review;S Welch;Ann Oncol,2010

2. Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis;E Galfrascoli;Dig Liver Dis,2011

3. Anti-angiogenic therapies for metastatic colorectal cancer;AD Wagner;Cochrane database of systematic reviews (Online),2009

4. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200;BJ Giantonio;J Clin Oncol,2007

5. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;LB Saltz;J Clin Oncol,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative Immunocite-Derived Ratios Predict Surgical Complications Better when Artificial Neural Networks Are Used for Analysis—A Pilot Comparative Study;Journal of Personalized Medicine;2023-01-01

2. Elevated serum neutrophil-lymphocyte ratio is associated with worse long-term survival in patients with HBV-related intrahepatic cholangiocarcinoma undergoing resection;Frontiers in Oncology;2022-10-17

3. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen;Cancers;2022-05-23

4. Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival;World Journal of Gastrointestinal Oncology;2022-01-15

5. Predictive “omic” biomarkers of drug response: Colorectal cancer as a model;Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy;2022